AbCellera Biologics Inc vs Global X Robotics and Artificial Intelligence ETF — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while Global X Robotics and Artificial Intelligence ETF trades at $37.92. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Global X Robotics and Artificial Intelligence ETF nearer its low. Which is the better fit depends on your goals.
| ABCL | BOTZ | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Health | — |
52-Week High | $9.76 | $41.63 |
52-Week Low | $2.78 | $31.99 |
Enterprise Value | $2.58B | — |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that are involved in the development of robotics and/or artificial intelligence. The fund is non-diversified.
Read more on BOTZ →